GET THE APP

A mucosal vaccine against hepatitis B and tetanus infections | 22120
Pediatrics & Therapeutics

Pediatrics & Therapeutics
Open Access

ISSN: 2161-0665

+44 1478 350008

A mucosal vaccine against hepatitis B & tetanus infections


2nd International Conference on Pediatrics & Gynecology

September 24-26, 2012 Marriott Hotel & Convention Centre, Hyderabad, India

Kalaiyarasi D, Jaganathan KS, Vamsi Krishna M and Krishnakumar D

Posters: J Pediatr Therapeut

Abstract :

Introduction: There is a need to develop combinational vaccine to induce strong systemic and mucosal immunity for Hepatitis B & Tetanus infection. Nasal vaccination is a promising alternative choice for conventional parenteral vaccination as it is non- invasive, capable of elicit strong systemic and mucosal immunity, it does not require needles, avoiding the pain and discomfort. The use of combination vaccines is a useful way to overcome the restrictions of multiple injections, especially for starting the immunization series for children behind schedule. Methods: In this study, the potential of combinational microparticle delivery system as nasal vaccine was investigated. Two type of microparticle formulations were prepared by using Hepatitis B Surface Antigen (HBsAg) and Tetanus Toxoid (TT) with PLGA as polymer. Tri Methyl Chitosan was used as a mucoadhesive coating material. The particle size, surface charge, morphology, protein loading efficiency, protein integrity, In vitro release studies, Fluorescence microscopy, In vivo immunological response was performed. Results: The TMC coated PLGA microparticles has an average size of 1-10μ and a positive zeta potential while PLGA microparticles shows negative zeta potential. The protein loading efficiency was found as above 80%. The antigen integrity was retained intact in encapsulated form as well as on release. The coated microparticles shows strong IgA level as compared to Aluminum adsorbed parenteral vaccines. Conclusion: Surface modified PLGA microparticles proved great potential as a nasal delivery system for combinational vaccines where humoral, cellular and mucosal responses are necessary particularly in conditions after bacterial and viral pathogens invade the host through the mucosal surface.

Biography :

D. Kalaiyarasi completed her M. Pharmacy in The Tamilnadu Dr.MGR Medical University, Chennai and pursuing Ph.D., in JNT University, Hyderabad. She has published various papers in reputed journals

Top